Kidney cancer
152 results
1 - 100
Kidney cancer 
Cytoreductive nephrectomy in metastatic renal cell carcinoma- Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma
- Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients
- Targeted therapy for advanced renal cell carcinoma
- Problems of childhood or adolescence cancer survivors in adulthood
- Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer
- Immunotherapy for metastatic renal cell carcinoma
- Sex and gender as predictors for allograft and patient‐relevant outcomes after kidney transplantation
- Targeted therapy for metastatic renal cell carcinoma
- Partial nephrectomy versus radical nephrectomy for clinical localised renal masses
- Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer
- HMG CoA reductase inhibitors (statins) for kidney transplant recipients
- Belatacept for kidney transplant recipients
- Steroid avoidance or withdrawal for kidney transplant recipients
- Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
Colon cancer screening may be beneficial for Lynch syndrome- Proteinuria
- Synbiotics, prebiotics and probiotics for people with chronic kidney disease
- Haematuria
- Effects of exposure to night shift work on cancer risk in workers
- Organ transplant recipient in primary health care
- Surgical management for upper urinary tract transitional cell carcinoma: Cochrane systematic review
- Gemcitabine for unresectable, locally advanced or metastatic bladder cancer: Cochrane systematic review
- Beta‐lactam versus beta‐lactam‐aminoglycoside combination therapy in cancer patients with neutropenia
- Antihypertensive treatment for kidney transplant recipients
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- Darbepoetin alfa minimally effective, increases stroke risk in diabetic nephropathy
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
- Bone‐modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta‐analysis
- Statin use is not associated with clinically important noncardiovascular benefits or harms
- Bone tumours
- Hydronephrosis and hydroureter - Video
- GLP-1 agonists are associated with a lower risk of obesity-related cancer than other glucose-lowering drugs
- Direct oral anticoagulants
- Leg oedema
- Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
- Green tea (Camellia sinensis) for the prevention of cancer
- Antithrombotic agents in primary health care
- Surgical management of localised renal cell carcinoma: Cochrane systematic review
- Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) for cancer‐related pain in children and adolescents
- Darbepoetin for the anaemia of chronic kidney disease
- Statins for improving renal outcomes
- Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies
- Statins for kidney transplant recipients
- Target of rapamycin inhibitors (TOR‐I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
- Physical exercise training interventions for children and young adults during and after treatment for childhood cancer
- Erythropoiesis‐stimulating agents for anaemia in chronic heart failure patients
- Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients
- Platinum‐containing regimens for triple‐negative metastatic breast cancer
- Silicosis (grinders' disease) and and other diseases caused by exposure to quartz dust
- Paracetamol (acetaminophen) for chronic non‐cancer pain in children and adolescents
- Chinese medicinal herbs to treat the side‐effects of chemotherapy in breast cancer patients
- Bisphosphonates for advanced prostate cancer
- The most important known health risks of smoking
- Platinum‐containing regimens for metastatic breast cancer
- Non‐surgical versus surgical treatment for oesophageal cancer
- Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease
- Simple hysterectomy with pelvic lymphadenectomy versus radical hysterectomy with pelvic lymphadenectomy for women with stage IA2‐IB1 cervical cancer
- Concomitant use of oral anticoagulants and SSRIs associated with increased risk of major bleeding
- Screening with urinary dipsticks for reducing morbidity and mortality
- Ultrasonographic examinations
- Gynaecological cancers
- Adverse effects of antineoplastic agents
- Elevated ESR (hypersedimentation)
- Rifaximin effective in decreasing post-TIPS hepatic encephalopathy in patients with cirrhosis
- Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections
- Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents
- Iron therapy in anaemic adults without chronic kidney disease
- Erythropoietin or darbepoetin for patients with cancer
- Multimodal interventions for cachexia management
- First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis
- Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
- Erythropoiesis‐stimulating agents for preventing acute kidney injury
- Urinalysis and bacterial culture
- Hyponatraemia
- Interleukin 2 receptor antagonists for kidney transplant recipients
- Early initiation of dialysis no better than delayed
- Perioperative antibiotics for preventing post‐surgical site infections in solid organ transplant recipients